234 related articles for article (PubMed ID: 27603348)
21. Management of Recurrent Tumefactive Multiple Sclerosis: Case Report and Literature Review.
Rissardo JP; Caprara ALF
Asian J Neurosurg; 2018; 13(3):893-896. PubMed ID: 30283576
[TBL] [Abstract][Full Text] [Related]
22. A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion.
Miyaue N; Yamanishi Y; Tada S; Ando R; Yabe H; Nagai M; Nomoto M
Mult Scler Relat Disord; 2019 Jun; 31():62-64. PubMed ID: 30933712
[TBL] [Abstract][Full Text] [Related]
23. Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Di Gregorio M; Torri Clerici VLA; Fenu G; Gaetani L; Gallo A; Cavalla P; Ragonese P; Annovazzi P; Gajofatto A; Prosperini L; Landi D; Nicoletti CG; Di Carmine C; Totaro R; Nociti V; De Fino C; Ferraro D; Tomassini V; Tortorella C; Righini I; Amato MP; Manni A; Paolicelli D; Iaffaldano P; Lanzillo R; Moccia M; Buttari F; Fantozzi R; Cerqua R; Zagaglia S; Farina D; De Luca G; Buscarinu MC; Pinardi F; Cocco E; Gasperini C; Solaro CM; Di Filippo M
Eur J Neurol; 2021 Apr; 28(4):1299-1307. PubMed ID: 33305459
[TBL] [Abstract][Full Text] [Related]
24. A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
Gnanapavan S; Jaunmuktane Z; Baruteau KP; Gnanasambandam S; Schmierer K
BMC Neurol; 2014 Apr; 14():68. PubMed ID: 24694183
[TBL] [Abstract][Full Text] [Related]
25. Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke.
Yacoub HA; Al-Qudahl ZA; Lee HJ; Baisre A; Souayah N
J Vasc Interv Neurol; 2011 Jul; 4(2):21-3. PubMed ID: 22518267
[TBL] [Abstract][Full Text] [Related]
26. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
[TBL] [Abstract][Full Text] [Related]
27. Late-onset multiple sclerosis mimicking brain tumor: a case report.
Iwamoto K; Oka H; Utsuki S; Ozawa T; Fujii K
Brain Tumor Pathol; 2004; 21(2):83-6. PubMed ID: 15700838
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Dilemma: An Atypical Case of Astrocytoma in a Patient with Relapsing-Remitting Multiple Sclerosis.
Kahovec C; Saini A; Levin MC
Neurol Int; 2021 Jun; 13(2):240-251. PubMed ID: 34204935
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in Tumefactive demyelinating lesions: A retrospective study.
Plowman RS; Varma H
J Neurol Sci; 2021 Sep; 428():117591. PubMed ID: 34333380
[TBL] [Abstract][Full Text] [Related]
30. Transtentorial herniation from tumefactive multiple sclerosis mimicking primary brain tumor.
Vakharia K; Kamal H; Atwal GS; Budny JL
Surg Neurol Int; 2018; 9():208. PubMed ID: 30488006
[TBL] [Abstract][Full Text] [Related]
31. Relapsing Tumefactive Demyelination: A Case Report.
Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
[TBL] [Abstract][Full Text] [Related]
32. [A case of pediatric multiple sclerosis presenting with a tumefactive demyelinating lesion].
Majima H; Ito T; Koyama N
Rinsho Shinkeigaku; 2017 Feb; 57(2):88-91. PubMed ID: 28132974
[TBL] [Abstract][Full Text] [Related]
33. Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Yamada S; Yamada SM; Nakaguchi H; Murakami M; Hoya K; Matsuno A; Yamazaki K; Ishida Y
J Med Case Rep; 2012 Apr; 6():104. PubMed ID: 22483341
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosis.
Kalinowska-Lyszczarz A; Tillema JM; Tobin WO; Guo Y; Fitz-Gibbon PD; Weigand SD; Giraldo-Chica M; Port JD; Lucchinetti CF
Mult Scler; 2022 Mar; 28(3):441-452. PubMed ID: 34212755
[TBL] [Abstract][Full Text] [Related]
35. Tumefactive Demyelinating Lesions in a Patient with Multiple Sclerosis Developed two Days after the Injection of Rituximab.
Moghadasi AN
Acta Neurol Taiwan; 2020 Dec; 29(4)():124-127. PubMed ID: 34018172
[TBL] [Abstract][Full Text] [Related]
36. Tumefactive Demyelinating Lesion Differentiated from a Brain Tumor Using a Combination of Magnetic Resonance Imaging and (11)C-methionine Positron Emission Tomography.
Ninomiya S; Hara M; Morita A; Teramoto H; Momose M; Takahashi T; Kamei S
Intern Med; 2015; 54(11):1411-4. PubMed ID: 26027998
[TBL] [Abstract][Full Text] [Related]
37. Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report.
Gavra M; Boviatsis E; Stavrinou LC; Sakas D
J Med Case Rep; 2011 Jun; 5():217. PubMed ID: 21649896
[TBL] [Abstract][Full Text] [Related]
38. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
39. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.
Kepes JJ
Ann Neurol; 1993 Jan; 33(1):18-27. PubMed ID: 8494332
[TBL] [Abstract][Full Text] [Related]
40. FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Dong A; Gao M; Wang Y; Gao L; Zuo C
Clin Nucl Med; 2016 Sep; 41(9):e414-6. PubMed ID: 26909714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
